Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer immunotherapy
4
×
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
investing
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
chronic kidney disease
crispr
eli lilly
generic drugs
immunotherapy
ipo
What
new
4
×
companies
life
science
bio
ipo
momentum
raised
roundup
week
approval
arrival
bails
biogen’s
biopharmaceutical
biotech
biotechs
brand
bridgebio
capital
car
club
continued
convo
crop
days
develop
drug
drugs
earlier
emerges
exceeded
failures
firm
firms
grab
group
hasn’t
haul
headlines
Language
unset
Current search:
national
×
new
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
